|
ZNF140 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.387400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.917200E-01 |
| Normal-vs-Stage2 |
8.944000E-01 |
| Normal-vs-Stage3 |
7.727000E-01 |
| Normal-vs-Stage4 |
9.544600E-01 |
| Stage1-vs-Stage2 |
8.626800E-01 |
| Stage1-vs-Stage3 |
7.666000E-01 |
| Stage1-vs-Stage4 |
9.463200E-01 |
| Stage2-vs-Stage3 |
7.530400E-01 |
| Stage2-vs-Stage4 |
9.636400E-01 |
| Stage3-vs-Stage4 |
8.209000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.997400E-01 |
| Normal-vs-AfricanAmerican |
2.629800E-01 |
| Normal-vs-Asian |
6.629400E-01 |
| Caucasian-vs-AfricanAmerican |
1.760180E-01 |
| Caucasian-vs-Asian |
7.836600E-01 |
| AfricanAmerican-vs-Asian |
6.885400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.678800E-01 |
| Normal-vs-Female |
7.537600E-01 |
| Male-vs-Female |
9.237000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.031400E-01 |
| Normal-vs-Extreme_Weight |
5.345600E-01 |
| Normal-vs-Obese |
5.484200E-01 |
| Normal-vs-Extreme_Obese |
4.042600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.683400E-01 |
| Normal_Weight-vs-Obese |
4.556800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.157800E-01 |
| Extreme_Weight-vs-Obese |
2.399200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.457000E-01 |
| Obese-vs-Extreme_Obese |
3.989400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.415190E-01 |
| Normal-vs-Age(41-60Yrs) |
2.200600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.403600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.447000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.767400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.822390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.196100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.530100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.097010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.052600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.303600E-02 |
| Normal-VS-Type2 PRCC |
4.384100E-03 |
| Normal-VS-KIRP CIMP |
6.150600E-01 |
| Normal-VS-Unclassified PRCC |
9.116000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.40349999797363E-08 |
| Type1 PRCC-VS-KIRP CIMP |
1.703980E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.157800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.925800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.873600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.257600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.670400E-02 |
| Normal-vs-N1 |
1.386410E-01 |
| Normal-vs-N2 |
1.985690E-02 |
| N0-vs-N1 |
4.439600E-03 |
| N0-vs-N2 |
2.369800E-01 |
| N1-vs-N2 |
5.323500E-02 |
|
|
